Panag Pharma Announces Health Canada License for a Topical Cold-Sore Formulation NPN 80084806

Panag Pharma announces Health Canada approval for a topical Cold-Sore Formulation, a new generation topical formulation with a dual mechanism of action that improves healing rates and reduces symptoms.

Panag Pharma Inc. Announces Initiation Of A Clinical Trial

Panag Pharma, Inc. launched a clinical trial evaluating the use of the newly NHP registered product Topical AOTC, a new generation topical for pain and pain associated with inflammation.